Cancer

October 31, 2024

Jeffrey Tosoian named chair of EDRN Prostate/GU Cancer Collaborative

The EDRN works to discover, develop and validate biomarkers and imaging methods to detect early-stage cancers, assess risk for developing cancer, and translate these tools into clinical tests.

By Craig Boerner
Michael Gibson, MD, PhD
October 30, 2024

Michael Gibson votes with FDA panel to limit immunotherapy indication 

The panel determined that allowing the wider indication would put patients at risk for adverse reactions from the two immunotherapies but without the added benefit in survival. 

By Tom Wilemon
October 18, 2024

Curbing late-stage breast cancer diagnosis: Innovative mobile diagnostic kit aims to improve early detection in Uganda

An international team of experts, including the Uganda Cancer Institute, is developing a groundbreaking mobile breast cancer diagnostic kit to enhance early detection in Uganda, where 70% of cases are diagnosed at an advanced stage.

By Kristin Centers
Cathy Eng, MD
October 15, 2024

Cathy Eng named Vanderbilt-Ingram Cancer Center associate director of Strategic Relations and Research Partnerships 

Her new responsibilities will include promoting clinical research by developing new strategic partnerships with pharmaceutical and biotech companies.

By Tom Wilemon
color-enhanced cross section of tumor tissue
October 7, 2024

New Video: Study shows cancer vaccine blocks tumor progression at early lesion stage

Senior author Mary Philip, MD, PhD, associate director of the Vanderbilt Institute for Infection, Immunology and Inflammation, talks about her Journal for ImmunoTherapy of Cancer study.
The findings support further vaccine investigation to make long-term, progression-free survival a reality for more cancer patients.

By Tom Wilemon
October 7, 2024

VUMC hosts International Lung Cancer Consortium meeting 

The consortium is coordinated by the International Agency for Research on Cancer with the aim of sharing data from ongoing lung cancer case-control and cohort studies.

By Tom Wilemon
October 4, 2024

‘Off-the-shelf’ CAR-T therapy shows promise for relapsed/refractory multiple myeloma 

The therapy, P-BCMA-ALL01, demonstrated a 91% overall response rate for the 23 patients participating in the phase 1 trial.
By Tom Wilemon
October 2, 2024

Clip In 4 the Cure

The high-energy fundraiser began in 2022 to raise money for cancer initiatives at Vanderbilt-Ingram Cancer Center and Monroe Carell Jr. Children's Hospital at Vanderbilt.
October 2, 2024

Grant funds quest to expand immunotherapy efficacy for colorectal cancer  

The study seeks to understand the mechanisms of colorectal cancer and builds on recent Vanderbilt research.
By Tom Wilemon
September 30, 2024

VUMC researchers awarded $1.9 million for AI-driven cancer data extraction

The project seeks to reduce the time for clinical chart abstraction by 90% while maintaining human-level accuracy.
By Paul Govern
September 27, 2024

Vanderbilt-Ingram Cancer Center part of new ‘Rewriting Cancer’ series

Launched Sept. 17-19 during the World Cancer Congress in Geneva, Switzerland, “Rewriting Cancer” aims to enhance understanding and inspire audiences by exploring the most innovative, inclusive and impactful solutions for cancer prevention, diagnosis, treatment and care globally.
By Tom Wilemon
September 24, 2024

Hyundai Hope on Wheels award bolsters pediatric cancer research

Since 2007, Hyundai Hope on Wheels, which includes funding from Hyundai Motor America and local dealerships, has awarded more than $2 million in funding to pediatric cancer researchers at Monroe Carell Jr. Children’s Hospital at Vanderbilt.
By Christina Echegaray
September 20, 2024

Fever drives enhanced activity, mitochondrial damage in immune cells

The mechanistic understanding of how cells respond to heat could explain how chronic inflammation contributes to the development of cancer.
By Leigh MacMillan
1 2 3 4 … 69